Microbot Medical Inc (NASDAQ:MBOT) does about 2.52M shares in volume on a normal day but saw 5996668 shares change hands in the recent trading day. The company now has a market cap of 90.58M USD. Its current market price is $2.49, marking a decrease of -11.39% compared to the previous close of $2.81. The 52 week high reached by this stock is $3.38 whilst the lowest price level in 52 weeks is $0.82.
The consensus objective for the share price is $9.00, suggesting that the stock has a potential upside of 72.33% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on January 13, 2020 when H.C. Wainwright reiterated the stock to “Buy” and issued a price target of between $12 and $26. Ladenburg Thalmann initiated its price target at $1.75.
The current price level is -5.61%, 6.55%, and 61.59% away from its SMA20, SMA50, and SMA200 respectively, with the MBOT price moving below the 50-day SMA on current market day. Microbot Medical Inc (MBOT) stock is down -6.74% over the week and -2.73% over the past month. Its price is 122.32% year-to-date and 114.66% over the past year.
To reach the target analysts have set, the stock logically needs to grow 72.33 percent from here.
Outstanding shares total 36.38M with insiders holding 0.67% of the shares and institutional holders owning 6.52% of the company’s common stock. The company has a return on investment of -40.25% and return on equity of -66.48%. The beta has a value of 1.14. Price to book ratio is 2.99.
